IL95578A - A vaccine made from polysaccharide and protein - Google Patents

A vaccine made from polysaccharide and protein

Info

Publication number
IL95578A
IL95578A IL9557890A IL9557890A IL95578A IL 95578 A IL95578 A IL 95578A IL 9557890 A IL9557890 A IL 9557890A IL 9557890 A IL9557890 A IL 9557890A IL 95578 A IL95578 A IL 95578A
Authority
IL
Israel
Prior art keywords
streptococcus
group
protein
proteins
antigen
Prior art date
Application number
IL9557890A
Other languages
English (en)
Hebrew (he)
Other versions
IL95578A0 (en
Inventor
James L Michel
Dennis L Kasper
Frederick M Ausubel
Original Assignee
Gen Hospital Corp
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp, Brigham & Womens Hospital filed Critical Gen Hospital Corp
Publication of IL95578A0 publication Critical patent/IL95578A0/xx
Publication of IL95578A publication Critical patent/IL95578A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL9557890A 1989-09-15 1990-09-04 A vaccine made from polysaccharide and protein IL95578A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40803689A 1989-09-15 1989-09-15

Publications (2)

Publication Number Publication Date
IL95578A0 IL95578A0 (en) 1991-06-30
IL95578A true IL95578A (en) 1998-08-16

Family

ID=23614587

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9557890A IL95578A (en) 1989-09-15 1990-09-04 A vaccine made from polysaccharide and protein

Country Status (22)

Country Link
EP (1) EP0491865B1 (de)
JP (2) JPH05500455A (de)
KR (1) KR0180559B1 (de)
AT (1) ATE146081T1 (de)
AU (1) AU641439B2 (de)
CA (2) CA2383393A1 (de)
DE (1) DE69029396T2 (de)
DK (1) DK0491865T3 (de)
ES (1) ES2097154T3 (de)
FI (1) FI105154B (de)
GR (1) GR1002294B (de)
HU (1) HU219327B (de)
IE (1) IE903349A1 (de)
IL (1) IL95578A (de)
NO (1) NO313908B1 (de)
NZ (1) NZ235316A (de)
PL (3) PL167882B1 (de)
PT (1) PT95316A (de)
RU (1) RU2113234C1 (de)
WO (1) WO1991004049A1 (de)
YU (1) YU176490A (de)
ZA (1) ZA907297B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
ZA937034B (en) * 1992-09-24 1995-06-23 Brigham & Womens Hospital Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
EP0667787B1 (de) * 1992-09-24 2001-07-18 Brigham And Women's Hospital Gruppe b streptococcus typ ii und typ v polysaccharid-protein konjugate als impfstoffe
IL107458A0 (en) * 1992-11-02 1994-02-27 Gen Hospital Corp Conjugate vaccine against group b streptococcus
AU722078B2 (en) * 1992-11-02 2000-07-20 Brigham And Women's Hospital Conjugate vaccine against group B Streptococcus
US6015889A (en) * 1993-03-19 2000-01-18 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
SG47049A1 (en) * 1993-03-19 1998-03-20 Gunnar Lindahl Protein rib a cell surface protein that confers immunity to manu strains of the group b strepto-ccus process for purification of the protein reagent kit
US5439808A (en) * 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US5565204A (en) * 1994-08-24 1996-10-15 American Cyanamid Company Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
US5747287A (en) * 1995-04-28 1998-05-05 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US6284884B1 (en) 1995-06-07 2001-09-04 North American Vaccine, Inc. Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
WO1999033969A1 (en) * 1997-12-31 1999-07-08 Pincus Seth H A method of isolating a peptide which immunologically mimics microbial carbohydrates including group b streptococcal carbohydrates and the use thereof in a vaccine
CA2591510A1 (en) * 2004-12-22 2006-06-29 Novartis Vaccines And Diagnostics, Inc. Group b streptococcus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367222A (en) * 1980-06-09 1983-01-04 President And Fellows Of Harvard College Immune globulin specific to Group B streptococci
US4367223A (en) * 1980-06-09 1983-01-04 President And Fellows Of Harvard College Vaccine against Group B streptococci
US4356170A (en) * 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
NZ214503A (en) * 1984-12-20 1990-02-26 Merck & Co Inc Covalently-modified neutral bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins, and methods of preparing such polysaccharides and conjugates
DE3750139T2 (de) * 1986-04-16 1994-10-06 Brigham & Womens Hospital Bakterielle antigene, antikörper, impfstoffe und deren herstellung.
NZ225372A (en) * 1987-07-17 1991-04-26 Xoma Corp Immunotoxin composition comprising purified ricin-a-chain species

Also Published As

Publication number Publication date
CA2383393A1 (en) 1991-04-04
KR920703097A (ko) 1992-12-17
JPH05500455A (ja) 1993-02-04
PT95316A (pt) 1991-06-25
NO920942L (no) 1992-05-12
WO1991004049A1 (en) 1991-04-04
AU641439B2 (en) 1993-09-23
PL167882B1 (pl) 1995-11-30
NO920942D0 (no) 1992-03-11
GR900100692A (el) 1992-01-20
GR1002294B (el) 1996-05-03
EP0491865A4 (en) 1993-05-05
IL95578A0 (en) 1991-06-30
PL286898A1 (en) 1991-06-03
NO313908B1 (no) 2002-12-23
EP0491865A1 (de) 1992-07-01
ATE146081T1 (de) 1996-12-15
FI921111A0 (fi) 1992-03-13
JP3447713B2 (ja) 2003-09-16
DK0491865T3 (da) 1997-06-02
IE903349A1 (en) 1991-04-10
RU2113234C1 (ru) 1998-06-20
CA2066221C (en) 2002-07-23
YU176490A (sh) 1992-12-21
EP0491865B1 (de) 1996-12-11
PL168587B1 (pl) 1996-03-29
ES2097154T3 (es) 1997-04-01
HU219327B (en) 2001-03-28
CA2066221A1 (en) 1991-03-16
DE69029396T2 (de) 1997-06-05
KR0180559B1 (ko) 1999-03-20
HUT63770A (en) 1993-10-28
FI105154B (fi) 2000-06-30
DE69029396D1 (de) 1997-01-23
JP2001309795A (ja) 2001-11-06
ZA907297B (en) 1993-06-01
AU6519090A (en) 1991-04-18
PL167444B1 (pl) 1995-09-30
NZ235316A (en) 1992-11-25

Similar Documents

Publication Publication Date Title
US5843444A (en) Conjugate vaccine for group B streptococcus
US6426074B1 (en) Group B Streptococcus vaccine
AU689452B2 (en) Conjugate vaccine against group B streptococcus
US6716432B1 (en) Pneumolysin mutants and pneumococcal vaccines made therefrom
EP0695803A2 (de) Epitopische Regionen des Pneumokokken Oberflächen-Proteins A
EP0491865B1 (de) Konjugatimpfstoff für gruppe b-streptococcus
US7098182B2 (en) Nucleic acids and proteins from group B streptococcus
AU722078B2 (en) Conjugate vaccine against group B Streptococcus
Madoff et al. Surface structures of group B streptococci important in human immunity

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees